The DELFT (Drug Eluting stent for LeFT main) registry: the unknowns.

The DELFT (Drug Eluting stent for LeFT main) registry: the unknowns.

Bibliographische Detailangaben
1. Verfasser:	Taggart, D
Format:	Journal article
Sprache:	English
Veröffentlicht:	2008

Ähnliche Einträge

Drug eluting stents in left main stem stenosis: patients will pay the price.
von: Taggart, D
Veröffentlicht: (2007)

Late stent thrombosis 28 months post implantation of a left main coronary drug-eluting stent.
von: Schrale, R, et al.
Veröffentlicht: (2007)

Everolimus-eluting stents or bypass surgery for left main coronary artery disease.
von: Stone, GW, et al.
Veröffentlicht: (2016)

Incidence, predictors and management of left main coronary artery stent restenosis: a comprehensive review in the era of drug-eluting stents.
von: De Caterina, A, et al.
Veröffentlicht: (2013)

The sirolimus-eluting Cypher Select coronary stent for the treatment of bare-metal and drug-eluting stent restenosis: insights from the e-SELECT (Multicenter Post-Market Surveillance) registry.
von: Abizaid, A, et al.
Veröffentlicht: (2012)

Drug Release Analysis and Optimization for Drug-Eluting Stents
von: Hongxia Li, et al.
Veröffentlicht: (2013-01-01)

Studies of biodegradable drug-eluting tracheal stents
von: Ng, Anthony Herr Cheun
Veröffentlicht: (2012)

Clinical Outcomes of Drug-Eluting versus Bare-Metal In-Stent Restenosis after the Treatment of Drug-Eluting Stent or Drug-Eluting Balloon: A Systematic Review and Meta-Analysis
von: Yi-Xing Yang, et al.
Veröffentlicht: (2020-01-01)

Drug deposition in coronary arteries with overlapping drug-eluting stents
von: Olgac, Ufuk, et al.
Veröffentlicht: (2017)

A novel bioabsorbable drug-eluting tracheal stent
von: Zhu, G. H., et al.
Veröffentlicht: (2011)

Risk assessment score for drug eluting stent restenosis
von: Z. A. Gabbasov, et al.
Veröffentlicht: (2018-09-01)

Second Generation Drug-Eluting Stent Implantation versus Coronary Artery Bypass Grafting in the Treatment of Young Patients with Left Main and/or Multivessel Coronary Disease
von: Xue Chen, et al.
Veröffentlicht: (2020-01-01)

Three-Year Clinical Outcomes With the Cilotax Dual Drug-Eluting Stent vs Everolimus-Eluting Stents in Patients With Acute Myocardial Infarction
von: HyeYon Yu, PhD, et al.
Veröffentlicht: (2024-05-01)

A Strategy for the In-Silico Assessment of Drug Eluting Stents: A Comparative Study for the Evaluation of Retinoic Acid as a Novel Drug Candidate for Drug Eluting Stents
von: Dimitrios S. Pleouras, et al.
Veröffentlicht: (2025-01-01)

Long-term outcomes of IVUS-guided and angiography-guided drug-eluting stent implantation for left main coronary artery disease: a retrospective consort study
von: Qing Yang, et al.
Veröffentlicht: (2024-07-01)

Intravascular Ultrasound versus Angiography Guided Drug Eluting Stent Implantation in Patients with Left Main Coronary Artery Disease – A Systematic Review and Meta-Analysis
von: Kevin Karim, et al.
Veröffentlicht: (2024-01-01)

Numerical modeling of local pharmacokinetics associated with drug-eluting stent
von: Jahid Ferdous
Veröffentlicht: (2009)

Thrombotic occlusion of a drug-eluting stent - is IVUS mandatory.
von: Arnold, JR, et al.
Veröffentlicht: (2006)

Patient Safety Events Related to the Placement of Drug-Eluting Stents
von: Patient Safety Authority
Veröffentlicht: (2023-12-01)

MODERN COATING TECHNOLOGIES FOR DRUG ELUTING CORONARY STENTS (REVIEW)
von: E. Y. Zagorulko, et al.
Veröffentlicht: (2019-01-01)

Drug-Eluting Balloons versus Second-Generation Drug-Eluting Stents for Treating In-Stent Restenosis in Coronary Heart Disease after PCI: A Meta-Analysis
von: Wen-Juan Xiu, et al.
Veröffentlicht: (2018-01-01)

Hydro Delft
Veröffentlicht: (1942)

Safety and Efficacy of Second-Generation Drug-Eluting Stents in Real-World Practice: Insights from the Multicenter Grand-DES Registry
von: You-Jeong Ki, et al.
Veröffentlicht: (2020-01-01)

The ultrathin-strut everolimus-eluting stent in a real-world population: the Everythin multicenter registry
von: Juan Casanova-Sandoval, et al.
Veröffentlicht: (2025-02-01)

Diabetic and nondiabetic patients with left main and/or 3-vessel coronary artery disease: comparison of outcomes with cardiac surgery and paclitaxel-eluting stents.
von: Banning, A, et al.
Veröffentlicht: (2010)

Real-World Three-Year Clinical Outcomes of Biolimus-Eluting Stents versus Other Contemporary Drug-Eluting Stents in Patients with Acute Myocardial Infarction Patients: Data from the Korea Acute Myocardial Infarction Registry (KAMIR)
von: Ji Young Park, et al.
Veröffentlicht: (2021-01-01)

The Endovascular Therapy for In-Stent Restenosis After Fluoropolymer-Based Drug-Eluting Stent Implantation in Femoropopliteal Lesions
von: Kazunori Horie, MD, et al.
Veröffentlicht: (2025-01-01)

Stent Fracture after Everolimus-Eluting Stent Implantation
von: Ali S. Almasood, et al.
Veröffentlicht: (2011-01-01)

Saphenous Vein Graft Aneurysm after Drug-Eluting Stent Implantation: Treatment by Covered Stent
von: Kyriacos Papadopoulos, et al.
Veröffentlicht: (2021-01-01)

Subacute Drug-Eluting Stent Thrombosis Caused by Stent Underexpansion: Evaluation by Optical Coherence Tomography
von: Roberto Martín-Reyes, et al.
Veröffentlicht: (2011-01-01)

Longitudinal Stent Elongation: A Rare Complication of Third-Generation Drug-eluting Stent Platform
von: Dibya Kumar Baruah, et al.
Veröffentlicht: (2024-04-01)

High pressure post-dilatation is necessary to optimize deployment of drug-eluting stents for the treatment of in-stent restenosis
von: Blackman, D, et al.
Veröffentlicht: (2003)

Novel drug-eluting stent to reduce fibrosis-induced ureteral stricture
von: Fong, Timothy Ren Zhong
Veröffentlicht: (2015)

Durable versus biodegradable polymer drug-eluting stents in all-comers
von: Pascal Meier, et al.
Veröffentlicht: (2025-03-01)

Triple-vessel coronary artery aneurysms following drug-eluting stents
von: Immaneni Sathyamurthy, et al.
Veröffentlicht: (2023-01-01)

Drug-eluting stents for coronary artery disease in the perspective of bibliometric analysis
von: Ying Zeng, et al.
Veröffentlicht: (2024-02-01)

Long-term Outcomes of Drug-eluting Stents in Symptomatic Intracranial Stenosis
von: Soonchan Park, et al.
Veröffentlicht: (2013-02-01)

Revascularization for unprotected left main stem coronary artery stenosis stenting or surgery.
von: Taggart, D, et al.
Veröffentlicht: (2008)

Stent elution rate determines drug deposition and receptor-mediated effects
von: Tzafriri, Abraham R., et al.
Veröffentlicht: (2016)

Safety of MRI early after implantation of a drug-eluting stent.
von: Porto, I, et al.
Veröffentlicht: (2004)